Atrás
Precio Akeso, Inc. (09926.HK)
Gráfico del Precio de Acciones 09926.HK
AKESO (09926.HK)
Akeso, Inc.
HK$113.6
-2.06%
$-2.4
Mercado Regular: Jan 21, 13:31:14 HKT
Estadísticas clave
Cierre Anterior
$117.6
Precio de apertura
$116
Rango del día
$113 - $116.1
Rango de 52 semanas
$54 - $179
Volumen
3.6M
Volumen promedio
6.9M
EPS (TTM)
-1.07
Rendimiento de dividendos
--
Cap. de mercado
$104.6B
¿Qué es AKESO?
Akeso, Inc. Is an investment company, which engages in the research and development, production, and sale of biopharmaceuticals products. The company is headquartered in Zhongshan, Guangdong and currently employs 3,529 full-time employees. The company went IPO on 2020-04-24. The Company’s programs covering the therapeutic areas of oncology, autoimmune and metabolic diseases. The firm's products mainly include cadonilimab (PD-1/CTLA-4), ivonescimab (PD-1/VEGF), Ligufalimab (AK117, CD47), Pulocimab (AK109, VEGFR-2), ANNIKO (penpulimab, PD-1), and tagitanlimab (PD-L1) used in oncology fields as well as ebronucimab (PCSK9), ebdarokimab (IL-12/IL-23), and Gumokimab (AK111, IL-17) used in metabolic and autoimmune therapeutic fields.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved
